ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,262Medicare Part D Prescriptions Filled, Including Refills

Rank: 188 out of 1111

$482K Total Retail Price of All Prescriptions

Rank: 238 out of 1111

403 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 403 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 403 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 6,482 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LOVASTATIN 336 238 1 41
HYDROCODONE-ACETAMINOPHEN 298 188 S3 2 1
METFORMIN HCL 253 193 3 8
FUROSEMIDE 248 191 4 6
BENAZEPRIL HCL 237 184 5 97
LEVOTHYROXINE SODIUM 234 218 6 3
OMEPRAZOLE 226 180 7 4
GABAPENTIN 216 122 8 10
CITALOPRAM HBR 197 130 9 14
ATORVASTATIN CALCIUM 193 135 10 15
METOPROLOL TARTRATE 188 138 11 12
TRAMADOL HCL 160 127 12 13
AMLODIPINE BESYLATE 160 126 12 7
ENALAPRIL MALEATE 151 119 14 56
FLUTICASONE PROPIONATE 149 68 15 27
GLIPIZIDE 146 100 16 57
LISINOPRIL 139 119 17 2
SIMVASTATIN 136 110 18 5
CLOPIDOGREL 135 115 19 30
HYDROCHLOROTHIAZIDE 133 104 20 11
POTASSIUM CHLORIDE 120 86 21 9
SERTRALINE HCL 111 58 22 24
MELOXICAM 103 74 23 18
CYCLOBENZAPRINE HCL 101 46 R 24 37
ATENOLOL 101 85 24 22
WARFARIN SODIUM 97 91 26 19
PLAVIX 95 79 27 49
ACTOS 95 67 27 98
ZOLPIDEM TARTRATE 94 41 29 16
CARVEDILOL 85 59 30 21
SULFAMETHOXAZOLE-TRIMETHOPRIM 85 63 30 71
NEXIUM 79 54 32 26
AMOX TR-POTASSIUM CLAVULANATE 77 48 33 141
AZITHROMYCIN 73 52 34 39
JANUVIA 72 54 35 75
FLUOXETINE HCL 69 39 36 44
RANITIDINE HCL 66 54 37 29
PRAVASTATIN SODIUM 65 64 38 17
ISOSORBIDE MONONITRATE ER 65 51 38 73
POLYETHYLENE GLYCOL 3350 64 51 40 45
DONEPEZIL HCL 63 45 41 25
LANTUS 60 32 42 46
PROAIR HFA 59 21 43 38
DIOVAN 58 48 44 51
ALENDRONATE SODIUM 58 34 44 35
FENTANYL 55 15 S2 46 65
METOLAZONE 53 36 47 162
TRIAMTERENE-HCTZ 52 40 48 80
TIZANIDINE HCL 51 27 49 91
GEMFIBROZIL 51 30 49 92
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 1, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.